BRNSBarinthus Biotherapeutics plc American Depositary Shares
0.6217USDMkt Cap: 25.40M $P/E: —3d ago
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap25.40M $
Enterprise Value-23.54M $
Revenue (TTM)—
Gross Profit8.59M $
Net Income (TTM)-66.43M $
Revenue/Share—
Last Price0.6217 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.52
PEG—
EV/EBITDA0.75
EV/Revenue—
P/S—
P/B0.45
EPS (TTM)-1.02
EPS (Forward)-1.20
52W Range
0.619124% of range0.6300
52W High0.6300 USD
52W Low0.6191 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-89.52%
ROA-67.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-47.98M $
CapEx (TTM)37.00K $
FCF Margin—
FCF Yield-24.30%
Net Debt-49.00M $
Net Debt/EBITDA1.57
Balance Sheet
Debt/Equity0.15
Current Ratio5.54
Quick Ratio5.33
Book Value/Sh1.397 USD
Cash/Share1.452 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Upside (mean)+704.2%
Target Range4.000 USD – 6.000 USD
$4.000+704.2% to mean$6.000
# Analysts2
Ownership
Shares Out.40.85M
Float27.26M
Insiders19.81%
Institutions44.07%
Short Interest
Short Ratio1.1d
Short % Float0.18%
Short % Out.0.11%
Shares Short45.91K
Short (prev mo.)44.71K
Technical
SMA 500.6241 (-0.4%)
SMA 2000.6693 (-7.1%)
Beta-0.39
S&P 52W Chg19.18%
Avg Vol (30d)11.68K
Avg Vol (10d)22.35K
Technical Indicators
RSI (14)54.5
MACD-0.0014
MACD Signal-0.0088
MACD Hist.+0.0074
BB Upper0.6273 USD
BB Middle0.5860 USD
BB Lower0.5447 USD
BB Width14.10%
ATR (14)0.0452 USD
Vol Ratio (20d)0.35x